The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease
{{output}}
The aim of this study was to evaluate the impact of epoetin alfa (EPO) therapy on delaying progression to renal dialysis and quantify the associated medical cost savings in elderly chronic kidney disease (CKD) patients. Elderly (>/=65 years) dialysis patients ... ...
